Traditional Chinese medicine formula for treating early hepatocellular carcinoma

Abstract

The invention belongs to the technical field of traditional Chinese medicine, and relates to a traditional Chinese medicine formula for treating early hepatocellular carcinoma. The traditional Chinese medicine is prepared from, by weight, 15-20 parts of fructus evodiae, 15-20 parts of corydalis tuber, 15-20 parts of fiveleaf akebia fruits, 15-20 parts of mallotus apelta, 15-20 parts of calamus, 5-10 parts of the root of small diuranthera, 5-10 parts of gmelin sealavender herb, 15-20 parts of fructus amomi, 5-10 parts of compound of glauber-salt and liquorice, 10-15 parts of artemisia apiacea, 10-15 parts of cortex lycii radicis, 10-15 parts of a blackend swallowwort root, 10-15 parts of curcuma aromatica, 5-10 parts of herba chelidonii, 10-15 parts of mastic, 10-15 parts of myrrh and 5-10 parts of melia toosendan. The traditional Chinese medicine raw materials conform to regulations of the Pharmacopoeia of People's Republic of China, and are safe and reliable. The traditional Chinese medicine formula has the effects of soothing the liver and regulating the circulation of qi, strengthening the spleen and stomach and the like, also has the effect of clearing heat and relieving pain, and has the advantages of having the obvious curative effect on treating liver qi stagnation type early hepatocellular carcinoma, becoming effective rapidly, being high in cure rate, having no side effect and the like.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine formula for treating early liver cancer. Background technique [0002] Liver cancer is one of the most common malignant tumors in clinical practice. According to the latest statistics, there are about 600,000 new liver cancer patients in the world every year, ranking fifth among malignant tumors. Liver cancer is a high incidence rate in my country, generally more men than women. China is a big country with hepatitis B. Most of the liver cancer in our country develops on the basis of hepatitis B cirrhosis, and the number of patients with hepatitis C is also increasing gradually. After hepatitis B, it will also develop into liver cancer. At present, the incidence of liver cancer in my country accounts for more than half of the world's total, accounting for 55% of the global liver cancer patients. It has become a major killer that...

AI Technical Summary

Problems solved by technology

[0003] The main treatment methods for liver cancer include surgery, radiotherapy and chemotherapy, and traditional Chinese medicine. The traditional treatment method for liver cancer is surgical resection, but not all liver cancer patients are suitable for surgery. Only patients with good cardiopulmonary function, limited liver tumors, and no metastasis suitable for surgery